Fny Investment Advisers, LLC Silence Therapeutics PLC Transaction History
Fny Investment Advisers, LLC
- $164 Million
- Q1 2025
A detailed history of Fny Investment Advisers, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 7,000 shares of SLN stock, worth $35,420. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,000
Previous 17,515
60.03%
Holding current value
$35,420
Previous $120,000
84.17%
% of portfolio
0.01%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$15.3 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$14.1 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$11.2 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$10.1 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$9.36 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $182M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...